Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

BILL PROPOSES ORPHAN DRUG LIMITS

Dec. 2, 1991

GENESIS BUYS INTO DRUG DESIGN TECHNOLOGY

Dec. 2, 1991

FDA PANEL RECOMMENDS MYOSCINT

Nov. 27, 1991

CELGENE RAISES $28 MILLION IN OFFERING

Nov. 27, 1991

FAVORABLE REPORT SPURS LTIZ

Nov. 27, 1991

IMMUNE RESPONSE STUNG BY MERCK SETBACK

Nov. 27, 1991

GTI FILES FOR PUBLIC OFFERING

Nov. 27, 1991

FDA APPROVES HIV ANTIBODY REAGENT

Nov. 27, 1991

CHIRON, CETUS SET EXCHANGE RATIO

Nov. 27, 1991

GTI TO COLLABORATE WITH SANDOZ

Nov. 26, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...